Related Experiment Video

Updated: Jul 19, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Hepatitis C: a challenge to hepatologists and to the liver transplantation team

Ana de Lourdes Candolo Martinelli1, Andreza Correa Teixeira, Fernanda Fernandes Souza

  • 1Department of Medicine, FMRP, USP, Brazil. adlcmarti@fmrp.usp.br

Acta Cirurgica Brasileira
|October 3, 2006
PubMed

Insights

Hepatitis C (HCV) significantly impacts liver health, leading to cirrhosis and liver cancer. Early recognition of complications and pre-transplant HCV treatment are crucial for managing patients undergoing liver transplantation.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is a primary driver of liver cirrhosis and hepatocellular carcinoma.
  • HCV is the leading indication for liver transplantation globally.
  • Managing HCV in the context of liver transplantation presents unique challenges for hepatologists.

Purpose of the Study:

  • To review the epidemiological, clinical, and therapeutic aspects of Hepatitis C.
  • To emphasize the implications of these aspects for liver transplantation services and teams.
  • To provide recommendations for managing HCV in pre- and post-liver transplant patients.

Main Methods:

  • Literature review utilizing the Medline database.
  • Focused search on epidemiological, clinical, and therapeutic data related to Hepatitis C.
  • Analysis of the impact of HCV on liver transplantation outcomes.

Main Results:

  • Hepatitis C poses a significant challenge to hepatologists and liver transplant teams.
  • Current liver disease burden is a consequence of past HCV infections.
  • Early detection of HCV-related complications is essential.

Conclusions:

  • HCV treatment prior to liver transplantation is highly recommended whenever feasible.
  • Prompt recognition and management of HCV recurrence post-transplantation are critical.
  • Proactive strategies are needed to mitigate the long-term consequences of HCV infection in transplant candidates and recipients.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...